ViAging™ is currently collecting contact information for future enrollment for a study called Assessing the Effects of Regenerative Treatments on Biological Aging:  An Observational Ambispective Case Series to assess the effects of regenerative anti-aging treatments on biological aging.

This ambispective observational case study series evaluates both the retrospective and prospective data of subjects that have already received regenerative antiaging treatments and will undergo treatments in the future. This type of study design allows researchers to track changes in subjects’ biological aging over time and compare those changes to their chronological age, the time since birth.

This study is designed to serve as a crucial step in translating promising results into clinical context. This research approach is necessary due to the significant challenges associated with conducting anti-aging studies. There is an immediate need to gather real-world evidence on unproven regenerative antiaging interventions already being sought by individuals.

By leveraging the unique strengths of an ambispective observational study researchers will begin to address the significant knowledge gap surrounding regenerative antiaging therapies. This approach will allow for the collection of real-world safety and efficacy data, paving the way for more informed decision-making and, ultimately, the responsible translation of these therapies.

Additionally, this observational data can assist in validating candidate biomarkers of biological aging by correlating them with clinical outcomes in patients receiving regenerative antiaging therapies. This can help standardize the measurement of aging for future studies.

Your participation is critical to the advancement of our understanding of aging! 

The study is open to anyone 50 years of age or older who meets the study eligibility, is willing to complete an informed consent and monthly health questionnaire, agrees to provide medical history and records, information about regenerative anti-aging treatments, and blood work results every six months.

If you’d like to participate in the study when it launches, please provide your contact information by pressing the button below.